The mammalian ovarian lifespan is determined at the time of birth through a delicate balance of oocyte survival and apoptosis as primordial follicles form, and the mechanism by which germ cells die is not understood. We hypothesized that two BCL2 family proteins, BCL2 and MCL1, may be responsible for regulating neonatal oocyte survival. Previous work has shown that BCL2 is important for germ cell survival in adult mouse ovaries, but no work has been done to examine its role at the time of birth. To elucidate the effects of BCL2 in the neonatal ovary, we examined ovaries of both Bcl2-overexpressing and knockout transgenic mice. When compared to wild-type mice, neither Bcl2 overexpression nor abrogation significantly altered ovarian histology. Another BCL2 family protein, MCL1, is expressed in human oocytes during ovarian development, suggesting a role for MCL1 in oocyte survival. To test this, we first examined the expression of MCL1 in the newborn mouse ovary. MCL1 was localized to both oocytes and somatic cells during primordial follicle formation. Subsequently, we used an in vitro organ culture system to identify a role for MCL1 in oocyte survival. We found that inhibition of MCL1 with an antibody to MCL1 in culture resulted in a reduced number of germ cells and an increase in cyst breakdown. Our data demonstrate that while BCL2 is not likely involved in perinatal oocyte survival, MCL1 may be an important regulator of the ovarian primordial follicle reserve. apoptosis, cyst breakdown, follicular development, oocyte development, primordial follicle formation
INTRODUCTION
The endowment of germ cells in a mammalian female is determined at the time of her birth, and the process that establishes this reserve is complex. In mouse, germ cells arrive at the potential gonad at approximately 10.5 days postcoitum (dpc) and begin to divide rapidly by mitosis until 13.5 dpc [1] . Because of incomplete cytokinesis, the oogonia remain connected by intercellular bridges, forming germ cell cysts [2] . Once mitosis has ended, oogonia enter meiosis, proceed through the stages of prophase I, and subsequently arrest in the diplotene stage beginning at 17.5 dpc. Germ cells, now known as oocytes, become separated from each other as cysts begin to break down and individual oocytes become surrounded by granulosa cells, forming primordial follicles. Cyst breakdown and follicle formation are gradual, lasting until postnatal day (PND) 5 [3, 4] . Coincident with cyst breakdown is a large loss of germ cells, and at the end of this process, only about onethird of the initial endowment of oocytes remains [5] . How and why oocytes are selected for either death or survival remains a mystery.
Loss of oocytes occurs at three different time periods in germ cell development, but in all cases, this death is thought to be due to apoptosis [5] [6] [7] . Members of the BCL2 family of proteins are known regulators of apoptosis and can be divided into two discrete groups of molecules, those that are proapoptotic (BAX, BAK, BAD, BID) and those that are antiapoptotic (BCL2, BCL-X, MCL1) [8] . BCL2 molecules share some degree of protein homology because each protein contains at least one BCL2 homology (BH) domain, BH3. These domains are thought to be crucial for protein-protein interactions between family members, and it is the interactions and balance of family members that determine cell fate. BCL2 and the other antiapoptotic family members have three to four BH domains as well as a transmembrane domain. Some proapoptotic members such as BAX share this structure while others contain only the BH3 domain.
BCL2 and other antiapoptotic BCL2 family proteins bind to proapoptotic BCL2 family members such as BAX at the mitochondrial membrane, keeping them inactive [9] . When activated, BAX homodimers form, serving as pores that allow mitochondrial cytochrome C to enter the cytoplasm. Cytochrome C associates with caspase 9 and apoptotic peptidase activating factor 1 (APAF1), forming the apoptosome and activating downstream effector caspases, which in turn activate apoptosis [10] .
A role for several BCL2 family proteins has been established in germ cell survival. Knockout of the proapoptotic Bax gene in the murine ovary resulted in an increased number of oocytes in fetal, neonatal, and adult mouse ovaries [11, 12] . The antiapoptotic protein, BCL2, has been identified as a possible regulator of germ cell death in female mice because both overexpression and knockout of the Bcl2 gene alter ovarian germ cell numbers [7, 13] . Additionally, Hartley and colleagues [14] found that the antiapoptotic MCL1 protein was expressed in human oocytes during the time when primordial follicles are forming. MCL1 has a structure similar to BCL2 with three BH domains and a transmembrane domain [8] . MCL1 is also believed to function in a manner similar to BCL2, blocking the function of proapoptotic family members.
Although studies on Bax have determined a role for proapoptotic BCL2 family members, no research to date has elucidated which antiapoptotic members are important for oocyte survival in the perinatal ovary. Based on observations that BCL2 manipulation alters adult ovarian histology and that MCL1 protein is expressed in human fetal ovary, we hypothesize that either BCL2, MCL1, or both proteins may play a role in determining final oocyte numbers. Here, we show that neither knockout nor overexpression of BCL2 results in a change in germ cell numbers, while inhibition of MCL1 significantly decreases the number of oocytes in newborn ovaries. Our findings establish MCL1 as a likely regulator of female fecundity.
MATERIALS AND METHODS

Animals
For Bcl2 deletion studies, Bcl2 heterozygous mice were obtained from Jackson Laboratories. Heterozygotes were bred using timed matings to produce homozygous Bcl2 knockout mice. The morning after mating, female mice were examined for vaginal plugs, and the presence of a plug was denoted 0.5 dpc. Pregnant mice delivered at 19.5 dpc (PND 1) and pups were sacrificed at PND 1, 4, and 7 and genotyped; ovaries were examined for oocyte number, follicle formation, and progression. BCL2-overexpressing mice in an FVB background were obtained from Jodi Flaws [13] . These mice were generated in the Flaws laboratory by fusing the Bcl2 gene to the Kit promoter, allowing overexpression of the BCL2 protein in oocytes. KIT is expressed in dividing primordial germ cells and oogonia but is downregulated as the germ cells enter meiosis [15] . KIT is upregulated in oocytes when they reach the diplotene state of prophase I of meiosis, which occurs coincident with primordial follicle formation [16] . Thus, in the BCL2-overexpressing mice, we expect that BCL2 is ectopically expressed in primordial germ cells and oogonia until meiotic entry at 13.5 dpc and then again in the oocytes as they reach diplotene arrest starting at 17.5 dpc. Adults were mated using timed matings; pups were sacrificed at PND 1, 4, and 7, and ovaries were examined for oocyte number, follicle formation, and progression. For BCL2-overexpression controls, adult FVB mice were also obtained from Jodi Flaws and mated, and the pups' ovaries were analyzed at PND 1, 4, and 7.
For the MCL1 studies, adult male and female C57BL/6 mice were purchased from Jackson Laboratories. Adults were bred using timed matings to produce offspring for the experiments. Pregnant mice delivered at 19.5 dpc (PND 1), and pups were euthanized for either in vitro ovary organ culture at PND 1 or immunohistochemistry on 15.5 dpc, 17.5 dpc, or PND 1, 3, or 5.
All the mice were housed under 12L:12D cycles, with temperatures of 218C-228C, and had free access to chow and water. All the animal protocols were approved by the Syracuse University Institutional Animal Care and Use Committee.
Genotyping Tissue for Bcl2 Knockout Studies
Tail biopsies were collected from pups generated by mating Bcl2 heterozygotes and lysed in 20 ll proteinase K and 180 ll tissue lysis buffer (ATL; Qiagen) overnight at 658C. DNA was extracted using the Qiagen DNeasy kit. PCR was run on a program of 30 cycles of 948C for 1 min, 578C for 1 min, and 728C for 1 min. To amplify the wild-type (WT) allele forward and reverse primers (Eurofins MWG/OPERON), 5 0 -CTT TGT GGA ACT GTA CGG CCC CAG CAT GCG-3 0 and 5 0 -ACA GCC TGC AGC TTT GTT TTC ATG GTA CAT C-3 0 were used. To amplify the mutant allele forward and reverse primers, 5 0 -CCG GTT CTT TTT GTC AAG ACC G-3 0 and 5 0 -CGG CAG GAG CAA GGT GAGAT-3 0 were used.
Antibodies
STAT3 (C20) (Santa Cruz Biotechnology) and VASA (Abcam) antibodies were each used at a dilution of 1:500 for immunohistochemistry. MCL1 and BCL2 antibodies (Santa Cruz Biotechnology) were used at a dilution of 1:100 for immunohistochemistry. TUNEL (terminal deoxynucleotidyl tranferase dUTP nick end labeling) (Intergen) was used to visualize dying cells by immunohistochemistry. Secondary antibodies, goat anti-rabbit Alexa 488, and goat anti-rabbit Alexa 568 (Invitrogen) were used at a dilution of 1:200.
In Vitro Ovary Organ Culture
Ovaries from PND 1 female mice were harvested and placed on 0.4 lm floating filters (Millicell-CM; Millipore Corp) in 0.4 ml culture media consisting of D-MEM/HAM F12 Media (Invitrogen), 0.1% Albumax (Invitrogen), 0.1% bovine serum albumin (Fisher), 5 3 ITS-X (Life Technologies), 0.05 mg/ml L-ascorbic acid (Sigma), and penicillin-streptomycin (Life Technologies) in 4-well dishes (Nunc) as previously described [17] . A single drop of media was placed on each of the ovaries to keep them hydrated.
To assess MCL1 function in the ovary, ovaries were cultured for 3 days in either media alone, media supplemented with a rabbit polyclonal antibody to MCL1 (S-19; Santa Cruz) in a 1:100 dilution, or media supplemented with immunoglobulin G (IgG) (Santa Cruz) in a 1:100 dilution (n ¼ 8 ovaries per group). For cell death studies, a second group of ovaries were cultured in control or anti-MCL1 supplemented media for 2 days (n ¼ 8 ovaries per group). At the conclusion of the culture, all the ovaries were prepared for whole-mount immunohistochemistry.
Immunohistochemistry
Ovaries were fixed in 5% electron microscopy-grade paraformaldehyde (Electron Microscopy Sciences) overnight at 48C and stained as previously described [2] . Whole ovaries were labeled with primary antibody overnight and then with anti-rabbit secondary antibody. Nuclei were labeled with TOTO-3 or propidium iodide (Invitrogen). A Zeiss LSM 710 confocal microscope was used to image the ovaries. As a control, some ovaries were labeled with only anti-rabbit secondary antibody.
To detect the uptake of MCL1 antibody by live ovarian cells, ovaries were first cultured either in control media or in media containing the anti-MCL1 antibody overnight. Ovaries were then fixed in 5% paraformaldehyde overnight and labeled with anti-rabbit secondary antibody. The nuclei were labeled with propidium iodide, and the ovaries were then imaged.
Analysis of Germ Cell Cyst Breakdown and Follicle Development
For both BCL2 and MCL1 studies, oocytes were labeled with STAT3 antibody, a known marker of germ cells, and imaged with confocal microscopy [18] . For each ovary, two cores were visualized and counted. A core is a region 135 3 135 lm consisting of optical sections at four different depths in the ovary JONES AND PEPLING each 15-20 lm apart. Thus, for each ovary, two cores were obtained consisting of four optical sections per core for a total of eight optical sections per ovary. The number of oocytes found in cysts relative to the total number of oocytes was determined for each ovary by analyzing each section and reported as percent single oocytes. In order to determine whether oocytes were in cysts or not, for each of the four optical sections in a core, a z-stack of images each 1 lm apart was obtained with five images above the section and five images below the section being analyzed. This allowed us to determine whether an oocyte was part of a germ cell cyst above or below the plane of focus. Follicle development was determined by counting the number of primordial, primary, and secondary follicles present in relation to the total number of follicles found and reported as percent primordial, primary, or secondary follicles.
Analysis of Oocyte Numbers
Oocyte numbers were determined by counting the number of germ cells found within each optical section used for analyzing cyst breakdown and follicle development. The numbers were averaged and reported as number of oocytes per section. The number of oocytes per section is used as a proxy for the total oocytes per ovary; therefore, only ovaries that appeared to be of similar size and depth were used for counting oocyte numbers.
Analysis of Cell Death
To visualize dying germ cells, ovaries were first labeled for cell death using the TUNEL kit (Intergen) according to manufacturer's specifications and subsequently labeled for the germ cell marker VASA. Ovaries were then imaged with confocal microscopy. In each ovary, four optical sections were visualized and analyzed by counting the number of TUNEL-positive cells relative to the total number of cells present. This measure was reported as percent TUNEL-positive cells per ovary.
Statistical Analysis
A Student t-test was used to analyze the effects of BCL2 overexpression in the ovary. The effects of blocking MCL1 activity in the ovary and Bcl2 knockout results were analyzed with a one-way ANOVA using SPSS statistical software. For all the results, P values less than 0.05 were considered significant.
RESULTS
Expression of BCL2 Protein in Neonatal Ovaries
To test the expression of BCL2 protein in neonatal ovaries, ovaries from 15.5 dpc, 17.5 dpc, and PND 1, 3, and 5 mice were harvested, fixed, and labeled with an antibody to the BCL2 protein. Figure 1 shows that BCL2 protein is expressed primarily in the cytoplasm of oocytes at all ages and appears more strongly expressed in the oocyte at PND 3 and 5. Additionally, the protein appears to be weakly expressed in the somatic cells.
BCL2 Overexpression Does Not Alter Oocyte Survival or Cyst Breakdown
BCL2 overexpression was previously shown to increase the number of oocytes and primordial follicles in mouse ovaries at PND 12 [13] . Therefore, we questioned whether this difference originated during the neonatal period. To answer this, we examined neonatal ovaries from mice overexpressing BCL2. In the transgenic strain used, BCL2 was expressed under control of the KIT promoter, which drives expression in primordial germ cells and oogonia until 13.5 dpc and in oocytes starting at BCL2, MCL1, AND OOCYTE SURVIVAL 17.5 dpc. Ovaries were collected from both BCL2-overexpressing mice and FVB control neonatal mice at PND 1, 4, and 7, fixed, and labeled with the oocyte marker STAT3. Oocyte numbers, cyst breakdown, and follicle progression were examined. Control and overexpressing mice had an equal number of oocytes per section at PND 1 and oocyte number decreased at the same rate by PND 4 and 7 ( Fig. 2A) . The drop in oocytes/section was statistically significant in both the WT and overexpressing mice. Cyst breakdown was also similar between BCL2-overexpressing and FVB control mice at PND 1, 4, and 7. Overexpressing mice had 65.0% single oocytes, and control mice had 72.1% single oocytes at PND 7 (Fig. 2B) . Again, there was no effect of BCL2 overexpression on follicle progression as the percentage of follicles per optical section was similar in control and overexpressing mice (Fig. 2C) . Figure 2 , D and E, show representative confocal sections from control and BCL2-overexpressing ovaries, respectively. Therefore, it does not appear that increasing BCL2 protein in the ovary alters the number of oocytes during the neonatal period.
Targeted Disruption of Bcl2 Does Not Affect Germ Cell Survival or Oocyte Cyst Breakdown
To examine whether deletion of ovarian Bcl2 would result in a decrease in the number of oocytes in the perinatal period, we harvested ovaries from Bcl2 knockout mice and determined oocyte numbers, cyst breakdown, and follicle progression. No significant differences were seen in oocyte numbers at any age among Bcl2
, and Bcl2 À/À ovaries (Fig. 3A) . Similarly, Bcl2 knockout had no effect on cyst breakdown (Fig. 3B) . Likewise, deletion of Bcl2 had no effect on follicle progression as the percentage of follicles per optical section was similar in control and knockout mice (Fig. 3C) . Again, representative confocal sections from WT and Bcl2 knockout ovaries are shown (Fig. 3, D and E) . From these results, BCL2 protein does not seem to play a role in determining oocyte survival during the perinatal wave of apoptosis and follicle formation.
MCL1 Is Expressed in Oocytes
MCL1 has been shown to be expressed in the human ovary during primordial follicle formation, the time when oocyte loss is highest [14] , and we questioned whether it was also expressed in the neonatal mouse ovary during this same process. We harvested fetal mouse ovaries at 15.5 and 17.5 dpc and neonatal ovaries at PND 1, 3, and 5 and fixed and labeled them with an antibody to the MCL1 protein. Figure 4 , A-C, shows the lack of expression of MCL1 at 15.5 dpc. At 17.5 dpc, MCL1 expression is detected and appears to increase in oocytes between 17.5 dpc and PND 3 (Fig. 4, D-L) . MCL1 expression appears to decrease but remains in the oocyte at PND 5 (Fig. 4, M-O) . From 17.5 dpc onward, MCL1 expression can also be detected in the somatic cells so it is possible that this protein is involved in oocyte or somatic cell survival during the fetal or neonatal time period.
Live Cells Are Able to Take Up MCL1 Antibody in Culture
We found that MCL1 was expressed in the mouse ovary during follicle formation and wanted to test the effects of an JONES AND PEPLING MCL1 function-blocking antibody in ovary organ culture. To determine whether the MCL1 antibody could access the cytoplasm of live cells, we first cultured PND 1 ovaries in either control media alone or in media supplemented with the MCL1 antibody. After 24 h, ovaries were fixed and incubated with the secondary antibody to detect the presence or absence of the MCL1 antibody within oocyte or somatic cells. As expected, no MCL1 antibody is detected in control ovaries (Fig. 5A ). Figure 5 , B and C, shows the presence of the MCL1 antibody in the cytoplasm of both oocytes and somatic cells. Approximately 12% of the oocytes were positive for internalized antibody. This demonstrates the ability of living ovarian cells to take up the MCL1 antibody while in culture.
Inhibition of MCL1 in Organ Culture Reduces Oocyte Survival and Promotes Cyst Breakdown in a DoseDependent Manner
Because MCL1 protein was present at PND 1, we wanted to test the effects of blocking the protein on germ cell survival. We harvested ovaries at PND 1 and placed them in organ culture for 3 days either in control media alone, media supplemented with IgG, or in media supplemented with a function-blocking antibody to MCL1 at a dilution of 1:200, 1:100, or 1:50. After culture, the ovaries were then fixed and labeled for the oocyte marker STAT3 to examine oocyte survival, cyst breakdown, and follicle progression. Ovaries treated with antibody at 1:200 show a slight but nonsignificant decrease in the number of germ cells present (8.5 oocytes) from control and IgG ovaries (11.8 and 10.7 oocytes; Fig. 6A ). However, ovaries treated with anti-MCL1 antibody at 1:100 showed a large decrease in the number of oocytes present after 3 days in culture (4.2 oocytes) when compared with both control and IgG treated ovaries (Fig. 6A) . Further loss of oocytes was observed when the MCL1 antibody was used at a dilution of 1:50 in culture with treated ovaries containing only 1.1 oocytes (Fig. 6A) . Interestingly, the decrease in the number of oocytes was statistically significant between treatment groups as well, showing a dose response effect of the antibody on germ cell survival. After 3 days in culture, cyst breakdown was also affected by MCL1 inhibition at both the 1:100 and 1:50 dilutions. Treatment with 1:100 MCL1 antibody caused a slight increase in cyst breakdown, with treated ovaries containing 85.3% single oocytes. Treatment with 1:50 MCL1 antibody resulted in a statistically significant increase, with treated ovaries containing 92.8% single oocytes versus 76.7% in IgG-treated ovaries and 70.7% single oocytes in control ovaries (Fig. 6B) . Follicle progression, however, was unaffected by MCL1 antibody treatment at all three dilutions, with control and IgG-and anti-MCL1-treated ovaries demonstrating similar percentages of primordial, primary, and secondary follicles in relation to the total number of follicles (Fig. 6C) . Figure 6 , D and E, are representative confocal sections of control and anti-MCL1-treated ovaries, respectively.
Cell Death Is Increased When Treated with an Antibody to MCL1
To confirm that inhibition of MCL1 indeed resulted in increased oocyte death, we grew PND 1 ovaries overnight in organ culture. Ovaries treated with the antibody to MCL1 show a statistically significant increase in apoptosis with 14% TUNEL-positive cells compared with only 4.9% in controls (Fig. 7A) . Representative confocal sections showed a larger number of cells labeling with TUNEL in MCL1-treated ovaries when compared with controls (Fig. 7, B and C) . These results demonstrate a role for MCL1 in the survival of oocytes and primordial follicle formation in the neonatal mouse ovary. C) . Localization of MCL1 antibody was detected by labeling with a secondary antibody (green) and nuclei were labeled with propidium iodide (red). In A, arrow shows an example of lack of MCL1 labeling in oocytes of a control ovary and arrowhead shows a somatic cell without labeling. In B, arrow demonstrates the ability of live oocytes to take up the MCL1 antibody (green). In C, arrowhead shows MCL1 antibody (green) taken up by somatic cells. Bar ¼ 20 lm.
BCL2, MCL1, AND OOCYTE SURVIVAL
DISCUSSION
Previous studies have demonstrated a role for BCL2 in establishing and maintaining the ovarian reserve [7, 13] . Flaws et al. [13] reported an increase in the number of primordial follicles when BCL2 was overexpressed in the mouse ovary. At PND 8, overexpressors had more primordial follicles than control animals. In addition, by PND 60, the Bcl2 transgenic mice have the same number of oocytes as control mice, indicating that these extra germ cells are not maintained in the adult. Time points earlier than PND 8 were not examined so it was not known when the difference in oocyte numbers occurred. We hypothesized that this difference may be due to a reduction in perinatal oocyte apoptosis. To test this, we analyzed newborn ovaries from Bcl2 transgenic mice. Contrary to our prediction, we did not see an increase in the number of oocytes at any time point, suggesting that BCL2 protein is not important for germ cell survival in early neonatal life. However, it must be pointed out that we did not examine these mice at PND 8 to show that we also observed the difference in primordial follicle number as shown by Flaws and colleagues [13] and therefore cannot definitively state that BCL2 is not required for neonatal oocyte survival. It is formally possible that the original phenotype has not been maintained in these mice. Also, overexpression only occurred in oocytes, and the effects of overexpression in somatic cells were not examined. Using Bcl2 knockout mice, Ratts and colleagues [7] found a reduction in the number of primordial follicles at PND 42, but earlier time points were not examined. However, based on the results from our overexpression studies, we hypothesized that the reduction found in the previous study would not be a result of increased oocyte death during perinatal oocyte apoptosis. To confirm our findings that BCL2 was not necessary for oocyte survival in the newborn ovary, we examined neonatal Bcl2 knockout mouse ovaries. Again, no significant differences were noted in the number of germ cells between WT and Bcl2 mutant ovaries, suggesting that Bcl2 is dispensable for neonatal oocyte survival. However, as in the case for the BCL2 overexpression, we did not examine adult Bcl2 knockout mouse ovaries to confirm that we could observe the later effects shown by Ratts et al. [7] .
Although we found no role for BCL2 in perinatal germ cell survival, previous work demonstrated that manipulation of BCL2 protein levels altered ovarian histology, specifically in the endowment of primordial follicles [7, 13] . Recently, Tingen et al. [19] showed that there is a large loss of prepubertal primordial follicles in the mouse ovary beginning at PND 6. It is possible that the BCL2 protein is responsible primarily for the survival of primordial follicles during this later time period. Further studies examining the effects of ablating the Bcl2 gene on primordial follicle numbers after PND 6 would shed more light on the importance of the protein in prepubertal follicle survival.
We found that the MCL1 protein was increasingly expressed in murine oocytes from 17.5 dpc through PND 3, the window of time when primordial follicles form and the greatest amount of oocyte death is occurring in the ovary [5] . Similarly, Hartley et al. [14] reported that MCL1 was expressed in human oocytes during the time of primordial follicle formation and oocyte death, suggesting that MCL1 may be conserved across mammalian species as an important prosurvival factor for the subset of germ cells that survive during the massive germ cell apoptosis that accompanies primordial follicle formation. More importantly, the findings suggest a role for MCL1 in germ cell survival during cyst breakdown and primordial follicle formation.
To test whether the MCL1 protein is important for oocyte survival, we used an in vitro organ culture system because knockout of Mcl1 results in embryonic lethality [20] . Ovaries cultured in the presence of an antibody to MCL1 demonstrated a decrease in the number of oocytes present. This reduction in germ cell numbers was also dose dependent, indicating that there is a threshold in the level of MCL1 protein required for survival within oocytes. Because MCL1 is a known antiapoptotic protein [21] , we suspected that the reduction in the number of oocytes was due to an increase in apoptosis when MCL1 was inhibited in culture. This hypothesis was supported by the increase in the TUNEL assay found in ovaries treated with the antibody to MCL1 overnight in culture. The TUNELlabeled oocytes did not costain with the oocytes marker. However, we believe these cells are oocytes that have lost antibody reactivity for the oocyte marker. This has been observed previously in studies of TUNEL-labeled ovaries [5] . Thus, we cannot confirm that the TUNEL-labeled cells are oocytes. MCL1 is expressed in both the oocytes and somatic cells during the time of our culture, and thus we also cannot conclude that the blocking antibody is acting directly on the oocytes. The effect could be indirect with the antibody acting on the somatic cells. In any case, MCL1 appears to be not only expressed in the murine ovary, but also is a key regulator of germ cell survival during the time of germ cell loss, cyst breakdown, and primordial follicle formation.
It is thought that oocyte cyst breakdown may be reliant on germ cell death because these two processes are temporally correlated in the ovary [5] . Support for this idea comes from several studies demonstrating that a delay in cyst breakdown is associated with an increase in germ cell number [17, [22] [23] [24] . Greenfeld and colleagues [11] found that lack of the proapoptotic BCL2 family protein, BAX, led to a decrease in oocyte death and a reduction in cyst breakdown. Likewise, we found that when MCL1 was inhibited and germ cell death increased, the rate of cyst breakdown and the percentage of single oocytes also increased. These findings suggest that oocyte death may be involved in the regulation of cyst breakdown. Alternatively, it is possible that the mass germ cell apoptosis caused by MCL1 inhibition left only a few, single oocytes remaining.
To our knowledge, we are the first to use an antibody in ovarian culture that targets an internal cellular protein. Guo and colleagues [25] successfully utilized antibodies targeted to the phosphatase of regenerating liver proteins, proteins localized inside the cell, to ablate cancer cells. Within their study, they were able to demonstrate the ability of both live CHO and cancer cell lines to take up the PRL antibodies using a cell culture system. By showing the presence of the MCL1 antibody in the cytoplasm of both oocytes and somatic cells after culture, we have confirmed the findings by Guo and colleagues [25] that live cells can, in fact, allow antibodies access to internal portions of the cell in vitro. We found a low percentage of oocytes positive for internalization of the MCL1 antibody. More oocytes may have taken up the antibody but may not have been identified as oocytes because they were further along in the cell death process. In addition, the BCL2, MCL1, AND OOCYTE SURVIVAL internalization process is likely inefficient and only some oocytes take up the antibody. In any case, this is an exciting finding because it may lead to the ability to examine more ovarian cell-signaling pathways inside of oocytes and somatic cells utilizing antibodies that target intracellular proteins.
The experiments presented here are the first to examine the involvement of BCL2 antiapoptotic family members in perinatal oocyte survival and cyst breakdown. We have shown that while BCL2 itself does not play a role in early germ cell survival, MCL1 is important for preventing oocyte death during cyst breakdown and primordial follicle formation. A conditional knockout model of MCL1 should be developed and examined in the future to determine if our in vitro organ culture studies reflect what is truly happening in the animal. In addition, how MCL1 works to affect cell death remains a mystery and should be a focus of future studies. Previous work on BCL2 family members has demonstrated that these molecules may heterodimerize with proapoptotic members such as BOK, BOD, BAK, and BAX at the mitochondria [9, 26] or can regulate cellular calcium levels at the endoplasmic reticulum to inhibit apoptosis [27] . It would be interesting to discover where and how MCL1 prevents oocyte death in the ovary during mass germ cell apoptosis. Finally, future work needs to identify the molecules that regulate the action of MCL1 in the oocyte to prevent germ cell death. New studies revealing the mechanisms by which MCL1 regulates the size of the primordial follicle pool would give insight into the establishment and maintenance of the ovarian lifespan and may lead to new discoveries in the regulation of primordial follicle formation and fertility.
